
Dialybrid secures €15 million series A round
Dialybrid announces the closing of a €15 million series A round led by new lead investor XGEN Venture, with the participation of CDP Venture Capital (Rilancio Fund). The financing will fund the clinical validation of Dialybrid’s Silkothane® Arteriovenous Graft as…
Read More
Dialybrid announces successful first-in-human implant of Silkothane® Arteriovenous Graft for vascular access in hemodialysis
The first-in-human clinical trial, investigating the use of Dialybrid’s Silkothane® Arteriovenous Graft as a hemodialysis vascular access in patients who need hemodialysis, has started enrolling, and the first patient has been successfully implanted by coordinating principal investigator Prof. Matteo Tozzi,…
Read More
Dialybrid @ LSI Europe ’26 Emerging MedTech Summit, BARCELONA
Dialybrid announces its participation in the next edition of LSI Europe ’26 Emerging MedTech Summit in Barcelona, one of the key international gatherings for the MedTech and healthcare innovation ecosystem, bringing together executives, presenting startups, and active investors. Dialybrid Chief…
Read More
Dialybrid @ San Giovanni Rotondo
Dialybrid Project Coordinator, Stefania A. Riboldi, was invited to attend the 5th Congress of the Vascular Access Society (Italian Chapter), held in San Giovanni Rotondo (Italy) on May 14th-16th, 2026, and present the latest progress of Silkothane® Arteriovenous Graft toward…
Read More
Dialybrid @ LSI Europe ‘25, London
Dialybrid attended LSI (Life Science Intelligence) Europe ’25 Emerging MedTech Summit, held in London (UK) on September 8th-11th, 2025, presenting the company and the preclinical development of Silkothane® Arteriovenous Graft, meeting investors and other emerging players, and exchanging views on…
Read More
Dialybrid @ Vas 2025, Padova
Dialybrid Project Coordinator, Stefania A. Riboldi, showcased the novel Silkothane® Arteriovenous Graft with an oral presentation at the 14th Congress of The Vascular Access Society (VAS), held in Padova (Italy) on April 3rd-5th, 2025. The results of the latest GLP…
Read More
Dialybrid @ VAS 2023, Porto
Dialybrid’s Project Coordinator, Stefania A. Riboldi, was present with an oral presentation at the 13th Congress of The Vascular Access Society, held in Porto (Portugal), April 27th-29th, 2023. The title of the speech was “Evaluation of safety and performances of…
Read More